The risks in plain language
These figures come from the Ferinject medicine information. They describe groups of people who received that medicine; your own risk depends on your health and treatment plan. Skin staining does not have one dependable rate across NHS guidance, so we do not attach a misleading number to it.
Common
Usually short-lived effects
Up to 1 in 10 people
Headache, nausea, dizziness, flushing and a rise in blood pressure are listed as common effects of ferric carboxymaltose (Ferinject). Mild discomfort or bruising can also occur where the cannula goes in. Tell us if anything feels unusual while the infusion is running.
Frequency varies
Iron leakage and skin staining
A reliable personal percentage cannot be given
If iron leaks outside the vein, it can cause pain, swelling and brown skin staining. The mark may fade slowly or be permanent. Tell your clinician immediately about pain, burning, swelling or a change in colour around the cannula, even if it seems minor, so the infusion can be stopped and checked.
Common blood-test finding
Low phosphate after Ferinject
At least 1 in 100 and fewer than 1 in 10
Ferinject can lower the phosphate level in your blood, often without symptoms. The risk of troublesome low phosphate matters more with repeated high-dose treatment or existing risk factors. Rarely, prolonged low phosphate can affect bones. Tell a clinician if new or worsening tiredness, muscle weakness or bone pain develops in the following days or weeks; a blood test may be needed.
Rare
Severe allergic reaction (anaphylaxis)
At least 1 in 10,000 and fewer than 1 in 1,000
A serious reaction can cause breathing difficulty, wheezing, swelling of the face or throat, a widespread rash, faintness or collapse. It is rare but can be life-threatening. Tell the team straight away if you feel unwell during treatment. The published range is for Ferinject generally, not a measured IronOx rate or a prediction for one person.
Other possible effects include rash, itching, muscle or joint aches and flu-like symptoms. Some reactions can begin hours or days after treatment. This page covers the main risks and does not replace the patient leaflet or your consent discussion.